Tech Center 1600 • Art Units: 1623 1673 1693
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18025380 | NOVEL USE OF SACCHARIDE ISOMERATE | Non-Final OA | DSM IP Assets B.V. |
| 18481266 | ANTIMICROBIAL COMPOSITION COMPRISING A MODIFIED ALKYL GLYCOSIDE AND AN ALKANEDIOL | Non-Final OA | The Procter & Gamble Company |
| 17413664 | STABLE AQUEOUS COMPOSITION COMPRISING OLIGOSACCHARIDES | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18042741 | Hygromycin A Compositions and Methods of Use | Non-Final OA | NORTHEASTERN UNIVERSITY |
| 18655876 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | Non-Final OA | Gilead Sciences, Inc. |
| 18555768 | CELLULOSE-BASED FILAMENTS, FILMS AND 3D OBJECTS AND METHODS OF MANUFACTURE THEREOF | Non-Final OA | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY |
| 18261499 | METHOD OF PREPARATION OF CARBOXYMETHYL CELLULOSE HAVING IMPROVED STORAGE STABILITY | Non-Final OA | NUTRITION & BIOSCIENCES USA 1, LLC |
| 18261304 | IMPROVED METHOD FOR THE PREPARATION OF COLLOIDAL MICROCRYSTALLINE CELLULOSE | Non-Final OA | NUTRITION & BIOSCIENCES USA 1, LLC |
| 18247049 | DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME | Non-Final OA | UNIVERSITY OF SOUTHAMPTON |
| 18264015 | THERMALLY MODIFIED STARCHES | Non-Final OA | ROQUETTE FRERES |
| 18251358 | COMPOSITIONS COMPRISING METHYL CYCLODEXTRINS FOR THE TREATMENT AND/OR PREVENTION OF HEPATIC STEATOSIS | Non-Final OA | ROQUETTE FRERES |
| 18558928 | A PROCESS FOR THE PREPARATION OF N4-HYDROXYCYTIDINE AND ITS DERIVATIVES | Non-Final OA | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH |
| 18036732 | METHODS OF OLIGONUCLEOTIDE-BASED AFFINITY CHROMATOGRAPHY | Final Rejection | DONALDSON COMPANY, INC. |
| 18321117 | AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS | Final Rejection | Boehringer Ingelheim Vetmedica GmbH |
| 18574869 | Low-Molecular-Weight HE800 Exopolysaccharide Derivatives with Anti-Cancer Properties and Uses Thereof | Non-Final OA | INSERM (Institut National de la Santé et de la Recherche Médicale) |
| 17776699 | A Method for Drying Human Milk Oligosaccharides | Final Rejection | Chr. Hansen A/S |
| 18278728 | HAIR GROWTH AGENT | Non-Final OA | ADJUVANT HOLDINGS CO., LTD. |
| 18568641 | GEMCITABINE ANTICANCER DERIVATIVE AND ANTICANCER PHARMACEUTICAL USE | Non-Final OA | ASCENTAWITS PHARMACEUTICALS, LTD. |
| 18561681 | UNNATURAL CONFIGURATION NUCLEOTIDE PRODRUG COMPOUNDS | Non-Final OA | Ligand Pharmaceuticals Incorporated |
| 18287136 | A TRIFLUOROMETHYL THIANTHRENIUM COMPOUND, PROCESS FOR PREPARING THE SAME AND THE USE THEREOF | Non-Final OA | Studiengesellschaft Kohle gGmbH |
| 17907716 | TREATMENT OF CORONAVIRUS INFECTIONS | Non-Final OA | TX MEDIC AB |
| 17785295 | LARGE SCALE PROCESS | Final Rejection | GALECTO BIOTECH AB |
| 17415314 | AMORPHOUS FORM OF 5-BROMOPYRIDIN-3-YL 3-DEOXY-3-[4-(3,4,5-TRIFLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL]-1-THIO-ALPHA-D-GALACTOPYRANOSIDE | Final Rejection | GALECTO BIOTECH AB |
| 18210356 | PROCESS OF FRACTIONATION AND RECOVERY OF FLAVONOIDS, TERPENES AND PREBIOTIC FIBER CONTAINING POLYSACCHARIDES FROM PLANT MATERIAL, USE OF PLANT MATERIAL, AND FLAVONOIDS, TERPENES AND PREBIOTICAL FIBER CONTAINING POLYSACCHARIDES | Non-Final OA | FIBER CITRUS INDÚSTRIA E COMÉRCIO LTDA. |
| 18038351 | HIGH-PURITY ß-NICOTINAMIDE MONONUCLEOTIDE (NMN) AND METHOD FOR PRODUCING SAME | Non-Final OA | MIRAILAB BIOSCIENCE INC. |
| 18196972 | TOPICAL COMPOSITIONS | Non-Final OA | Prime Performance Research LLC |
| 18127421 | USE OF GABAA RECEPTOR AS TARGET IN PREPARATION OR SCREENING OF DRUG FOR LOWERING BLOOD LIPID LEVEL, TREATING OBESITY, AND/OR IMPROVING METABOLISM | Non-Final OA | RUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE |
| 17759251 | Sugar Chain and Compositions Thereof and Use Thereof in Prevention and/or Treatment of Coronavirus Infection | Final Rejection | Institute of Process Engineering, Chinese Academy of Sciences |
| 18173209 | INTEGRATED PROCESSES FOR PECTIN ACTIVATION AND MILD EXTRACTION | Non-Final OA | CP Kelco ApS |
| 18022570 | PROCESS FOR PREPARING SUGAMMADEX | Final Rejection | Werthenstein BioPharma GMBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy